BioProcess Insider - News BioProcess International

Thermo Fisher $50m spend to support high single-use uptake

Single-use adoption has gone from niche applications to standard practice in biomanufacturing says Thermo Fisher, which is expanding its disposable capabilities. Thermo Fisher has laid down plans to expand its bioproduction equipment capacity through a $50 million (€45 million) investment on th ...

ProBioGen licenses duck cell line tech to Vaccitech for viral vaccines
Vaccitech has licensed the AGE1.CR duck retina cell line from ProBioGen to manufacture its viral vectored vaccines. The deal will see Universi ...
FDA issues draft guidance on biosimilar analytical studies
The draft guidance advises industry to minimize differences between a biosimilar and its reference biologic including in the choice of expression ...
Off-the-shelf CAR-T a ‘gamechanger’ for multiple myeloma, says Allogene
Allogene expects manufacturing specifications to be a focus of IND reviews as it looks to bring an off-the-shelf CAR-T therapy for multiple myelo ...
Regenxbio building Maryland AAV plant to support gene therapies
Regenxbio will construct a GMP facility in Maryland to produce adeno-associated viral vectors for its gene therapy programs using its NAV technol ...

Covering the whole development process for the global biotechnology industry

More From BioProcess Insider

Recent Tweets

Recent Tweets

Trending